You are here

Home › Monkeypox treatment trial begins in the Democratic Republic of the Congo › Monkeypox treatment trial begins in the Democratic Republic of the Congo

Monkeypox treatment trial begins in the Democratic Republic of the Congo

Primary tabs

Monkeypox treatment trial begins in the Democratic Republic of the Congo

Fri, 2022-10-14 10:55 — mike kraft
Monkeypox treatment trial begins in the Democratic Republic of the NIH partnering with INRB to evaluate tecovirimat (TPOXX). National Institutes of Health (NIH)

...

The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death.

...

 

Country / Region Tags: 
Africa
Democratic Republic of the Congo
Global
General Topic Tags: 
Mpox
Treatments
Contagion
Disease
Disease Prevention
Government
Medical Testing
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
Africa Resilience Initiative
Global Health
Medical - global
Vaccines
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.459 seconds.